Skip Navigation



NDT Advance Access published online on April 19, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh852
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/6/1274-a    most recent
gfh852v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bachmeyer, C.
Right arrow Articles by Demontis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachmeyer, C.
Right arrow Articles by Demontis, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Letter

Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis

Claude Bachmeyer 1*, Jean-François Cadranel 2, and Renato Demontis 3

1 Service de Médecine Interne, CHU Tenon, Paris, France
2 Unité d'Hépatogastroentérologie, Hôpital Laennec, Creil, France
3 Service de Néphrologie, Hôpital Laennec, Creil, France

* To whom correspondence should be addressed.
Claude Bachmeyer, E-mail: claude.bachmeyer{at}tnn.ap-hp-paris.fr



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
D E Furst, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, J Sieper, P Emery, E C Keystone, M H Schiff, P Mease, et al.
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii2 - iii22.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. A. Keogh, S. R. Ytterberg, F. C. Fervenza, K. A. Carlson, D. R. Schroeder, and U. Specks
Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial
Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 180 - 187.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.